Jeffrey P. Draime
President at Aeromax Aviation Holdings LLC
Net worth: 7 M $ as of 2024-06-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| James Zizelman | M | 63 | 4 years | |
| Matthew Horvath | M | 38 | 8 years | |
| Frank Sklarsky | M | 67 | 3 years | |
| Ira Kaplan | M | 70 | 15 years | |
| Paul Schlather | M | 71 | 15 years | |
| Mary Kim Korth | F | 69 | 18 years | |
| Sheila Rutt | M | 55 | 1 years | |
| Carsten Joachim Reinhardt | M | 55 | 1 years | |
| Susan Benedict | F | 57 | 7 years | |
| George Mayes | M | 65 | 12 years | |
| Mark Day | M | 52 |
Aeromics, Inc.
 Aeromics, Inc. BiotechnologyHealth Technology Aeromics, Inc. operates as a preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema (brain swelling) in stroke. It offers AER-271, a drug candidate that blocks aquaporin-4 (AQP4), the molecular water channel found at the blood-brain barrier and controls of cerebral edema in models for ischemic stroke, cardiac arrest, and water toxicity and blocks edema in models of cardiac ischemia and transplant. The company was founded by Marc F. Pelletier and Walter F. Boron in 2008 and is headquartered in Cleveland, OH. | 6 years |
| Salvatore Orsini | M | 53 | 2 years | |
| George Warren | M | - |
Quaker Steak & Lube, Inc.
 Quaker Steak & Lube, Inc. RestaurantsConsumer Services Quaker Steak & Lube, Inc. owns and operates food chain restaurants. It offers salads and soups, street food, sandwiches, baby back ribs and desserts. The company was founded by Gary Meszaros and George Warren in March 1974 and is headquartered in Westlake, OH. | 50 years |
| Stephen R. Fox | M | - | 9 years | |
| Thomas Zindrick | M | 65 |
Aeromics, Inc.
Aeromics, Inc. BiotechnologyHealth Technology Aeromics, Inc. operates as a preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema (brain swelling) in stroke. It offers AER-271, a drug candidate that blocks aquaporin-4 (AQP4), the molecular water channel found at the blood-brain barrier and controls of cerebral edema in models for ischemic stroke, cardiac arrest, and water toxicity and blocks edema in models of cardiac ischemia and transplant. The company was founded by Marc F. Pelletier and Walter F. Boron in 2008 and is headquartered in Cleveland, OH. | 6 years |
| Peter C. Agre | M | - |
Aeromics, Inc.
Aeromics, Inc. BiotechnologyHealth Technology Aeromics, Inc. operates as a preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema (brain swelling) in stroke. It offers AER-271, a drug candidate that blocks aquaporin-4 (AQP4), the molecular water channel found at the blood-brain barrier and controls of cerebral edema in models for ischemic stroke, cardiac arrest, and water toxicity and blocks edema in models of cardiac ischemia and transplant. The company was founded by Marc F. Pelletier and Walter F. Boron in 2008 and is headquartered in Cleveland, OH. | 5 years |
| Gary Meszaros | M | - |
Quaker Steak & Lube, Inc.
Quaker Steak & Lube, Inc. RestaurantsConsumer Services Quaker Steak & Lube, Inc. owns and operates food chain restaurants. It offers salads and soups, street food, sandwiches, baby back ribs and desserts. The company was founded by Gary Meszaros and George Warren in March 1974 and is headquartered in Westlake, OH. | 50 years |
| Peter Longo | M | - |
Aeromics, Inc.
Aeromics, Inc. BiotechnologyHealth Technology Aeromics, Inc. operates as a preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema (brain swelling) in stroke. It offers AER-271, a drug candidate that blocks aquaporin-4 (AQP4), the molecular water channel found at the blood-brain barrier and controls of cerebral edema in models for ischemic stroke, cardiac arrest, and water toxicity and blocks edema in models of cardiac ischemia and transplant. The company was founded by Marc F. Pelletier and Walter F. Boron in 2008 and is headquartered in Cleveland, OH. | 8 years |
| Dave Jenkins | M | - |
Aeromics, Inc.
Aeromics, Inc. BiotechnologyHealth Technology Aeromics, Inc. operates as a preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema (brain swelling) in stroke. It offers AER-271, a drug candidate that blocks aquaporin-4 (AQP4), the molecular water channel found at the blood-brain barrier and controls of cerebral edema in models for ischemic stroke, cardiac arrest, and water toxicity and blocks edema in models of cardiac ischemia and transplant. The company was founded by Marc F. Pelletier and Walter F. Boron in 2008 and is headquartered in Cleveland, OH. | 5 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Kenneth A. Kure | M | - | - | |
| Marc F. Pelletier | M | 53 |
Aeromics, Inc.
Aeromics, Inc. BiotechnologyHealth Technology Aeromics, Inc. operates as a preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema (brain swelling) in stroke. It offers AER-271, a drug candidate that blocks aquaporin-4 (AQP4), the molecular water channel found at the blood-brain barrier and controls of cerebral edema in models for ischemic stroke, cardiac arrest, and water toxicity and blocks edema in models of cardiac ischemia and transplant. The company was founded by Marc F. Pelletier and Walter F. Boron in 2008 and is headquartered in Cleveland, OH. | 12 years |
| George E. Strickler | M | 75 | - | |
| John C. Corey | M | 76 | 11 years | |
| Jonathan Blair de Gaynor | M | 57 | 8 years | |
| Robert Krakowiak | M | 53 | 5 years | |
| Thomas M. Dono | M | 51 | 3 years | |
| D. M. Draime | M | 90 | 41 years | |
| Regan Grant | F | - | - | |
| Kevin Heigel | M | 64 | 2 years | |
| Douglas C. Jacobs | M | 84 | 18 years | |
| Richard P. Adante | M | 77 | 6 years | |
| Robert Willig | M | - | 3 years | |
| Anthony L. Moore | M | 61 | 3 years | |
| Alisa A. Nagle | F | - | 4 years | |
| Daniel M. Kusiak | M | 54 | 7 years | |
| Laurent P. Borne | M | 49 | 5 years | |
| Kevin Kramer | M | 64 | 2 years | |
| Brad Corrodi | M | - | 3 years | |
| Thomas A. Beaver | M | 70 | 24 years | |
| Richard E. Maus | M | - | - | |
| Gerald V. Pisani | M | 83 | - | |
| Earl L. Linehan | M | 82 | 21 years | |
| Sheldon J. Epstein | M | 85 | 21 years | |
| Charles M. di Staulo | M | 66 | - | |
| Vincent F. Suttmeier | M | 66 | 10 years | |
| Mark J. Tervalon | M | 57 | 10 years | |
| Joseph M. Mallak | M | 58 | - | |
| Edward F. Mosel | M | 75 | 20 years | |
| Paul R. McGuirk | M | 72 |
Aeromics, Inc.
Aeromics, Inc. BiotechnologyHealth Technology Aeromics, Inc. operates as a preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema (brain swelling) in stroke. It offers AER-271, a drug candidate that blocks aquaporin-4 (AQP4), the molecular water channel found at the blood-brain barrier and controls of cerebral edema in models for ischemic stroke, cardiac arrest, and water toxicity and blocks edema in models of cardiac ischemia and transplant. The company was founded by Marc F. Pelletier and Walter F. Boron in 2008 and is headquartered in Cleveland, OH. | 11 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 49 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jeffrey P. Draime
- Personal Network
